Geneva, March 23 -- International Clinical Trials Registry received information related to the study (NCT07468175) titled 'A 16-week Clinical Study Investigating a Dark Spot Corrector Serum in Women With Moderate Discrete Hyperpigmentation' on March 2.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Revision Skincare
Condition:
Hyperpigmentation
Dark Spots
Intervention:
Other: Cosmetic dark spot corrector serum
Recruitment Status: Not recruiting
Phase: N/A
Date of First Enrollment: October 21, 2024
Target Sample Size: 48
Countries of Recruitment:
United States
...